Department of Organic Chemistry, Faculty of Pharmacy, Medical University, Chodźki 4a, 20-093 Lublin, Poland.
Eur J Med Chem. 2011 Nov;46(11):5717-26. doi: 10.1016/j.ejmech.2011.09.034. Epub 2011 Sep 28.
1-(indol-2-carbonyl)-4-(4-nitrophenyl)-thiosemicarbazide was synthesized and antibacterial and type IIA topoisomerases (DNA gyrase and topoisomerase IV) activity was evaluated. It was found that it shows activity against Gram-positive bacteria with MICs of 50 μg/mL and inhibitory action against topoisomerase IV with an IC(50) of 14 μM. Although modification of its structure resulted in molecules with a lower biological profile, our observations strongly implicate that thiosemicarbazide derivatives participate in at least two different mechanisms of antibacterial activity; one is connected with the inhibition of topoisomerase IV, while the nature of the other cannot be elucidated from the limited data collected thus far. The differences in bioactivity further investigated by the molecular modeling approach and docking studies suggest that inhibitory activity of 4-arylthiosemicarbazides is connected with electronic structure rather than the geometry of the molecule.
1-(吲哚-2-羰基)-4-(4-硝基苯基)-硫代缩氨基脲被合成,并对其抗菌和 IIA 拓扑异构酶(DNA 回旋酶和拓扑异构酶 IV)活性进行了评估。结果发现,它对革兰氏阳性菌具有活性,MIC 值为 50 μg/mL,对拓扑异构酶 IV 的抑制作用 IC(50)为 14 μM。尽管对其结构进行修饰导致生物活性降低,但我们的观察结果强烈表明,硫代缩氨基脲衍生物至少参与了两种不同的抗菌作用机制;一种与拓扑异构酶 IV 的抑制有关,而另一种机制则无法从目前收集到的有限数据中阐明。通过分子建模方法和对接研究进一步研究了生物活性的差异,表明 4-芳基硫代缩氨基脲的抑制活性与电子结构有关,而与分子的几何形状无关。